SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (213)1/30/2007 2:29:34 PM
From: keokalani'nui  Respond to of 397
 
Droxidopa is not why I bought CHTP. I really only care about the RA program. So, I've done v. little work on D, none. Safety ought not to be issue, at least.

x1504 matters to me. I did not expect to have to go through extend formulation work, but so far I am buying company's suggestions that it basically done and the issues were solved with easy, ususally successful methods.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News